Open to all suggestions!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m still in several OTC plays, just not this one. I follow lots of previous Synergy Shells for fun. This was a gem when it was LPHM, now not so much.
Well based on the tweet Ronn Maxwell is still alive. I was starting to wonder.
Pulled his old hydrogen assisted gas guzzling gooch-getter out of storage for a pic.
Ronn Ford, CEO of RONN Inc., proudly rolled out the original RONN SCORPION Hydrogen SuperCar and put it on display at GrayHawk Golf Course to support The Rotary Club raising funds for the OCJ Kids supporting Arizona Foster Children. $RONN pic.twitter.com/hWCBhLGOls
— RONN Motor Group, Inc. (@RONNMotorGroup) April 23, 2024
Based on the 10-K that’s correct.
No, I haven’t owned this for a while.
Correct, if I could see filings at Delaware SOS, we would probably know if the name change has already been filed. Based on the 10K this is their current status.
-To prepare and effectuate the spin out of Atlantic Energy Solutions, Inc. (currently being renamed CognoGroup), on February 13,, 2024, the Board authorized certain corporate actions, including the transfer of assets and liabilities between subsidiaries of the Company, the renaming of Recruiter.com Recruiting Solutions, LLC to CognoGroup, LLC, and the reorganization of Recruiter.com Recruiting Solutions, LLC to a subsidiary of Atlantic Energy Solutions, Inc.
You think they changed their mind? Just asking because, why buy the shell?
I don’t know why Miles would step down as CEO if he planned to do that to RCRT.
I guess it’s probable since the Fintech thing is questionable.
I think he wants to do something different with the spinout assets regarding AI.
JMHO.
There will be a 10-Q by 5/15 before the 6/30 final date on the JobMobz deal.
Could be other news between then, like maybe the website updates or Linked in Changes. Not sure for now.
We won’t know that until 4/30 when the February production data populates since management doesn’t seem apt to share their reporting.
Just seems odd to me since it could likely result in stocks inadvertently tiering down at OTC while they wait.
Thanks for the response, peaked my interest since I have other holdings waiting for Name / Ticker changes.
Saw this on $IGPK board.
Is this rule change accurate and if so where can it be found?
OTC has a new procedure. They will not allow a company access when they have filed to change their name at the State level until FINRA has approved the change. This is a process that can take several months to complete.
I don’t follow ABQQ, but I usually avoid most stocks run over in China. GLTU
Hoping to start hearing some things once the RCRT NaZ status is secure. That seems to be Miles focus at the moment.
I think mainly because the debt holders expect the shell to stay on Nasdaq. What institutional investor wants their stock dropping off to OTC.
Thanks Tre, that is pretty much what I was saying.
AESO is a separate filer than RCRT.
AESO files on OTC.
RCRT files through SEC.
If RCRT gets hit by SEC that’s their problem. RCRT owns the AESO shell for their recapitalization effort. That is why the didn’t list it as a subsidiary in the 10K.
Pg.5
Additionally, the Company owns a controlling interest in Atlantic Energy Solutions, Inc., a Colorado company that is traded on the OTC Markets (OTC:AESO).
Anyone here have Delaware SOS filing access? If, so go check and see if there is a name change filing under Recruiter.com Recruiting Solutions, LLC to Cognogroup, LLC.
And if you want or have time see if they applied for a Name change and ticker of Recruiter.com Group, Inc. I was curious whether they would change RCRTs Naz name &symbol since technically it was sold to JobMobz.
I don’t have access to Delaware SOS filings. And I don’t pay unless extremely necessary.
From the new 10-K
To prepare and effectuate the spin out of Atlantic Energy Solutions, Inc. (currently being renamed CognoGroup), on February 13,, 2024, the Board authorized certain corporate actions, including the transfer of assets and liabilities between subsidiaries of the Company, the renaming of Recruiter.com Recruiting Solutions, LLC to CognoGroup, LLC, and the reorganization of Recruiter.com Recruiting Solutions, LLC to a subsidiary of Atlantic Energy Solutions, Inc. Additionally, the Board of Directors authorized that management may take such steps necessary to change the name of Recruiter.com Group, Inc. to reflect its purpose and a corresponding change to the company’s stock symbol.
RCRT 10-k has no bearing on our OTC markets status. All the filings there are up to date for AESO, SOS filings too
I don’t own any, I just follow this stock because I’m highly curious why it has been propped up above .01.
That’s an OTC oddity I’m interested in watching until it finally falls. If it doesn’t it would confirm to me the directors have a deal with the convertible loan holder to keep it above the .01 threshold to retain their OTCQB rating. I’m treating it as a learning experience, nothing more really.
If and when I think it’s worth buying I would, but that is currently not the case IMO.
GLTU
Can anyone confirm this Michael Cohen is the newer board advisor? He is the only one I can find with any Oppenheimer connection.
https://www.linkedin.com/in/michaelcohen2?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app
https://saicvc.com/michael-cohen-bio/
I like the fact Dave said the new guy Dr.Hamman is already preparing a path to submit a clinical trial for the Kratom drug they’ve been working on.
I had not researched this dudes creds really until yesterday. He’s not a lightweight in his field.
Biography
Dr. Mark T. Hamann serves as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery, Biomedical Sciences and Public Health at the MUSC Colleges of Pharmacy and Medicine. He also holds Adjunct appointments with The University of Maryland’s Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine. Dr. Hamann began his career in cGMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota and then completed a Ph.D. degree in Organic Chemistry at the University of Hawaii, under the guidance of the late Professor Paul J. Scheuer. During his graduate studies he discovered the lead anticancer agent, kahalalide F which entered clinical trials with the help of the biotech company PharmaMar. Dr. Hamann completed Postdoctoral Studies with Prof Bill Baker at McMurdo Station in Antarctica and then spent 20 years as a faculty member and natural products researcher at The University of Mississippi School of Pharmacy. During his research career, Dr. Hamann has published over 250 scientific papers, reviews, book chapters and guided over 100 graduate students/postdoctoral fellows and visiting scholars. Dr. Hamann served as an Associate Editor for Biochimica et Biophysica Acta, General Subjects. Dr. Hamann with the aid of his students, has received a number of awards including an NIH New Investigator Award (R29) and a Career Development Award (KO2) from NIAID, an American Society of Pharmacognosy Young Investigator Award, The American Foundation for Pharmaceutical Education, Pharmacy Faculty New Investigator Award and The University of Mississippi, School of Pharmacy, Researcher of the Year Award. His group is actively involved in the isolation, structure determination and optimization of natural products and toxins with a focus on plant and invertebrate microbiomes. His group is currently working on the preclinical development of a small pipeline of natural products with activity against cancer, emerging infectious diseases and neuropsychiatric disorders. Dr. Hamann’s laboratory has worked on the optimization of processing methods and synthetic optimization of the chemical structures of the cannabinoids for potential applications in the control of pain, cancer and infectious diseases.
This company is toast, sorry, they sold the lab according to the filing and only have the 2 officers as employees accumulating salary debt.
All the drugs they pimp haven’t changed. And they still haven’t completed the Phase 1 FDA Pre-IND submission. The can’t afford it.
From filing:
We are currently identifying potential contract research organizations and clinical trial centers to conduct the Phase I/II(a) human proof of concept study, which is estimated to cost $6,500,000. As of the date of this filing, however, the Company does not have sufficient funds to complete the Phase I/II(a) study.
Subject to the results from our Phase I trials, we plan to submit an IND to the FDA for RCC-33 with the clinical protocol for a Phase II double-blind placebo controlled clinical trial evaluating RCC-33 in patients with CRC at various dosing levels versus placebo. The outcomes from the planned Phase II human proof of concept trial will inform our decision regarding further steps in the clinical development of RCC-33.
Go to OTC, they’re posted
I think the hearing is primarily to keep RCRT on the NAZ. I think the GOLQ merger was postponed in lieu of the licensing agreement specifically because the GOLQ crew wants a NAZ shell.
Personally I think the merger will go through later and it was in GOLQs best interest to support increasing the shareholder equity requirement with the licensing agreement to prevent the delisting. It’s no skin off them if they eventually own RCRT anyway.
As far as AESO receiving assets after the hearing, I think they already started the process of spinning things out. Closing out the Parrut, Inc requirements was the start of releasing MediaBistro from the RCRT balance sheet IMO. The other items mentioned Candidate Pitch, LinkedIn AI exchange, other AI Training courses belong to Miles and team and probably can release them easy since they weren’t part of any prior deal with GOLQ or JobMobz. The only deal I’m curious about now the RCRT had was the partnership with Millionways. I think that comes over too and was included in the Shareholder video presentation. What other deals or partnerships they have on tap are unknown.
We already know the proceeds and holdings from JobMobs deal and Futuris deal are already going to AESO, so it’s just a matter of time IMO.
$AESO
Be easier to tell how it will go if they had posted the 10K.
I was looking for it but it never came. Wondering if they plan to present it at the NAZ hearing 4/18. Very curious.
MDM Permian 2023 Annual Financials have posted. The shell risk has been removed and the stock is moving in the right direction. #mdmp #oilandgas
— mdmpermian (@mdmpermian) April 15, 2024
$MDMP making a nice move.
MDM Permian 2023 Annual Financials have posted. The shell risk has been removed and the stock is moving in the right direction. #mdmp #oilandgas
— mdmpermian (@mdmpermian) April 15, 2024
I sold my last original batch in the .20s then picked up this last crappy lot mid .02s thinking it may bounce too .10 or so. I was clearly wrong once they started selling into news. Almost dumped on that slow rise to .05 but held out.
Mainly came back on the off chance they might make some money off pre-selling carbon credits. Even if they never sell a real product they could possibly show some revenue from selling those climate scam hopes and dreams.
GLTU Bench
Technically I’ve never actually been burned here. I first bought LPHM at .06 before it ran to $1.19.
I did however buy some again that didn’t do too well, but I’m still deep green on what I made on this particular stock.
Doesn’t change the fact the mgmt here will continue to dilute because they have never sold one thing to generate revenue since 2009. Only made one supposed deal after another to generate buzz.
Only thing that bothers me about $BLEG stock is the obvious attempts by some retail traders and possibly a group to keep the price down. L2 clearly shows this.
Facts are facts pumper. More shares coming, watch them sell into the next PR or tweet like clockwork.
Yes, 46M was less than I expected with the volume increase.
I don’t think they will done for some time though. $RONN Jon will keep dumping.
GLTU
A little dilution?? Since 3/7/24 they added 213M to the OS. There is a reason they increased AS to 4B. I’m just going to assume they took full advantage of the pump crew that came in this past week. 3 days of 100M or so volume probably produced 50-100M more in the next OTC update. RONN has diluted with the last 5-6 PRs.
GLTU
Better off over at $B!EG IMO. These guys haven’t delivered a viable product since they built that hydrogen assisted car. That thing uses regular gasoline when you dig into the specs and I also think I saw some details about that in an old $VYDR filing.
No doubt!
Mr. Ford also added that with additional funding, First Nations is prepared to move forward with RONN Inc.
Translation:
We will be diluting a lot to get these native people interested in doing business with us.
Hahaha!
Next weeks April 18th NAS hearing on whether RCRT meets continued listing requirements is a big deal for AESO. I’m pretty positive based on DD they’ll be removed from any penalty’s and stay on Nasdaq, but it’s always up in the air in today’s market.
GLTA. $AESO
Well that could be debated, but it was a super clean one, I’d definitely put it top 3.
I think structure wise, BDCM or EVCI(TKVR) were better. But damn close. Those are in Chinese hands now with unknown outcomes.
LPHM was pretty damn nice though before tacking on that unnecessary 350M for this historically bad company. False promises since 2009 or so from my DD.
GLTU PennyStalker.
That was last weeks adds. With the past few days of hundred million volume next week will probably show 100M.
It’s just a pump to sell into news. Nobody seems to question why the tweets come from the account that’s not the official Ronn motor company account on X.
Morgan’s making a killing right now. those claiming shorts are just retarded.
Agree, all the $DJT boards are cracking me up. It’s a wild ride over there.